September 4, 2019 Cary Breese Chief Executive Officer NowRx, Inc. 2224 Old Middlefield Way Mountain View, CA 94043 Re: NowRx, Inc. Offering Statement on Form 1-A Filed August 14, 2019 File No. 024-11058 Dear Mr. Breese: We have reviewed your offering statement and do not have any comments. We will consider qualifying your offering statement at your request. If a participant in your offering is required to clear its compensation arrangements with FINRA, please have FINRA advise us that it has no objections to the compensation arrangements prior to qualification. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. We also remind you that, following qualification of your Form 1-A, Rule 257 of Regulation A requires you to file periodic and current reports, including a Form 1-K which will be due within 120 calendar days after the end of the fiscal year covered by the report. You may contact Jonathan Burr at 202-551-5833 or Pamela Howell at 202-551-3357 with any questions. Sincerely, Division of Corporation Finance Office of Beverages, Apparel and Mining